Results 21 to 30 of about 926 (210)
PLoS ONE, 2012 BackgroundAnti-obesity drugs are widely used to prevent the complications of obesity, however, the effects of anti-obesity drugs on cardiovascular risk factors are unclear at the present time.
Yu-Hao Zhou +9 more
doaj +1 more source
Anti-Obesity Drugs: A Review about Their Effects and Safety [PDF]
Diabetes & Metabolism Journal, 2012 The current recommendations for the treatment of obese people include increased physical activity and reduced calories intake. When the behavioral approach is not sufficient, a pharmacologic treatment is recommended.
Jun Goo Kang, Cheol-Young Park
doaj +1 more source
Pharmaceuticals, 2023 (1) Background: Obesity, a complex metabolic disease resulting from an imbalance between food consumption and energy expenditure, leads to an increase in adipocytes and chronic inflammatory conditions.
Ivana Cacciatore +13 more
doaj +1 more source
Obesity and type 2 diabetes: can we find a compromised treatment solution?
Сахарный диабет, 2017 Type 2 diabetes and obesity are two enormous epidemic diseases of the 21st century. Because obesity is a primary risk factor for type 2 diabetes development, patients with diabetes are frequently obese.
Gagik R. Galstyan +2 more
doaj +1 more source
Inhibitors of absorption as anti-obesity drugs.
Folia Pharmacologica Japonica, 2001 There are two types of anti-obesity agents which are classified as inhibitors of absorption: inhibitors of lipid and carbohydrate absorption. Inhibitors of lipid absorption consist of lipase inhibitor (orlistat, Nomma Herb's extract (CT-II) and fat substitute (olestra, sucrose polyester). Orlistat is now available as an anti-obesity drug in the USA and
TSUJI, Masatomi +2 more
openaire +3 more sources
Tremor and the anti‐obesity drug BRL 26830A. [PDF]
British Journal of Clinical Pharmacology, 1990 The thermogenic beta 3‐adrenoceptor agonist BRL 26830A has been shown to increase weight loss in dieting subjects but tremor was a frequent adverse effect. We have investigated the magnitude and nature of this tremor after a single oral dose in 18 subjects. Two complementary techniques were used to attach the recording apparatus to the subjects to give
A A, Connacher +5 more
openaire +2 more sources
A Lineup for Next Anti-Obesity Medicines: Beyond Incretin-Based Pharmacotherapy
PharmaceuticalsBackground/Objectives: Obesity is a chronic and multifactorial disease, and the global prevalence of obesity-induced metabolic and systemic complications is expected to rise. Current peptide-based drugs that mainly target glucagon-like peptide-1 receptor
Sangmin Lee, Hyeseon Song, Yeonwoo Kwon
doaj +1 more source
Heliyon, 2022 Obesity is one of the most common global health problems for all age groups with obese people at risk of a variety of associated health complications.
Freek Haerkens +7 more
doaj +1 more source
Rise and fall of anti-obesity drugs
World Journal of Diabetes, 2011 Although it is not generally a life-threatening disease, obesity is becoming a major health problem worldwide. It can be controlled by means of drugs, and, consequently, these are required to be safe as well as effective. In this paper, we summarize the fate of various drugs that have been introduced for clinical use in the treatment of obesity ...
Cheung, BMY, Li, MF
openaire +4 more sources
Molecules, 2022 Fruits and vegetables are important components of a healthy diet. They are rich sources of vitamins and minerals, dietary fibre and a host of beneficial non-nutrient substances including plant sterols, flavonoids and other antioxidants.
Azrina Azlan +3 more
doaj +1 more source